Literature DB >> 23052301

Bacteremic pneumonia caused by extensively drug-resistant Streptococcus pneumoniae.

Cheol-In Kang1, Jin Yang Baek, Kyeongman Jeon, So Hyun Kim, Doo Ryeon Chung, Kyong Ran Peck, Nam Yong Lee, Jae-Hoon Song.   

Abstract

The emergence of antimicrobial resistance threatens the successful treatment of pneumococcal infections. Here we report a case of bacteremic pneumonia caused by an extremely drug-resistant strain of Streptococcus pneumoniae, nonsusceptible to at least one agent in all classes but vancomycin and linezolid, posing an important new public health threat in our region.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23052301      PMCID: PMC3502956          DOI: 10.1128/JCM.01642-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong.

Authors:  P L Ho; T L Que; D N Tsang; T K Ng; K H Chow; W H Seto
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.

Authors:  Ross Davidson; Rodrigo Cavalcanti; James L Brunton; Darrin J Bast; Joyce C S de Azavedo; Pamela Kibsey; Christine Fleming; Donald E Low
Journal:  N Engl J Med       Date:  2002-03-07       Impact factor: 91.245

3.  Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.

Authors:  A-P Magiorakos; A Srinivasan; R B Carey; Y Carmeli; M E Falagas; C G Giske; S Harbarth; J F Hindler; G Kahlmeter; B Olsson-Liljequist; D L Paterson; L B Rice; J Stelling; M J Struelens; A Vatopoulos; J T Weber; D L Monnet
Journal:  Clin Microbiol Infect       Date:  2011-07-27       Impact factor: 8.067

4.  Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin.

Authors:  C Fogarty; R Goldschmidt; K Bush
Journal:  Clin Infect Dis       Date:  2000-08       Impact factor: 9.079

5.  Breakthrough pneumococcal bacteraemia in patients treated with clarithromycin or oral beta-lactams.

Authors:  D Van Kerkhoven; W E Peetermans; L Verbist; J Verhaegen
Journal:  J Antimicrob Chemother       Date:  2003-03       Impact factor: 5.790

6.  Risk factors associated with colonization by pneumococci with reduced susceptibility to fluoroquinolones in adult outpatients.

Authors:  M Raquel Marín Jiménez; Juan Luis Muñoz Bellido; José Angel García Rodríguez
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

7.  Evolution of erythromycin-resistant Streptococcus pneumoniae from Asian countries that contains erm(B) and mef(A) genes.

Authors:  Kwan Soo Ko; Jae-Hoon Song
Journal:  J Infect Dis       Date:  2004-07-13       Impact factor: 5.226

8.  Emergence of Streptococcus pneumoniae with very-high-level resistance to penicillin.

Authors:  Stephanie J Schrag; Lesley McGee; Cynthia G Whitney; Bernard Beall; Allen S Craig; Miriam E Choate; James H Jorgensen; Richard R Facklam; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

9.  A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease.

Authors:  Mark C Enright; Brian G Spratt
Journal:  Microbiology (Reading)       Date:  1998-11       Impact factor: 2.777

10.  Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae from Asian countries: ANSORP study.

Authors:  Won Sup Oh; Ji Yoeun Suh; Jae-Hoon Song; Kwan Soo Ko; Sook-In Jung; Kyong Ran Peck; Nam Yong Lee; Yonghong Yang; Anan Chongthaleong; Cheng-Hsun Chiu; Adeeba Kamarulzaman; Navartnam Parasakthi; M K Lalitha; Jennifer Perera; Ti Teow Yee; Gamini Kumarasinghe; Celia C Carlos
Journal:  Microb Drug Resist       Date:  2004       Impact factor: 3.431

View more
  6 in total

1.  Mechanism of β-lactam action in Streptococcus pneumoniae: the piperacillin paradox.

Authors:  Jules Philippe; Benoit Gallet; Cécile Morlot; Dalia Denapaite; Regine Hakenbeck; Yuxin Chen; Thierry Vernet; André Zapun
Journal:  Antimicrob Agents Chemother       Date:  2014-11-10       Impact factor: 5.191

2.  Black cobra (Naja naja karachiensis) lysates exhibit broad-spectrum antimicrobial activities.

Authors:  Mehwish Sagheer; Ruqaiyyah Siddiqui; Junaid Iqbal; Naveed Ahmed Khan
Journal:  Pathog Glob Health       Date:  2014-03-13       Impact factor: 2.894

Review 3.  Rise of the microbes.

Authors:  Michael J Mahan; Jessica Z Kubicek-Sutherland; Douglas M Heithoff
Journal:  Virulence       Date:  2013-01-18       Impact factor: 5.882

4.  Extensively drug-resistant Streptococcus pneumoniae, South Korea, 2011-2012.

Authors:  Sun Young Cho; Jin Yang Baek; Cheol-In Kang; So Hyun Kim; Young Eun Ha; Doo Ryeon Chung; Nam Yong Lee; Kyong Ran Peck; Jae-Hoon Song
Journal:  Emerg Infect Dis       Date:  2014-05       Impact factor: 6.883

5.  Novel Levofloxacin-Resistant Multidrug-Resistant Streptococcus pneumoniae Serotype 11A Isolates, South Korea.

Authors:  Miey Park; Hyun Soo Kim; Han-Sung Kim; Ji Young Park; Wonkeun Song; Hyoun Chan Cho; Jae-Seok Kim
Journal:  Emerg Infect Dis       Date:  2016-11       Impact factor: 6.883

Review 6.  Antimicrobial resistance in Asia: current epidemiology and clinical implications.

Authors:  Cheol-In Kang; Jae-Hoon Song
Journal:  Infect Chemother       Date:  2013-03-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.